Sabra Health Care REIT, Inc.
SBRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -2.04 | 1.07 | 0.15 |
| FCF Yield | 7.68% | 9.11% | 11.00% | 10.88% |
| EV / EBITDA | 15.58 | 18.30 | 17.09 | 31.58 |
| Quality | ||||
| ROIC | 5.02% | 3.93% | 2.37% | 0.33% |
| Gross Margin | 67.71% | 41.57% | 73.97% | 75.21% |
| Cash Conversion Ratio | 2.45 | 21.85 | -4.07 | -3.15 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.02% | 4.37% | 1.44% | -5.18% |
| Free Cash Flow Growth | 3.32% | -4.80% | -2.18% | 29.50% |
| Safety | ||||
| Net Debt / EBITDA | 5.78 | 7.71 | 8.21 | 13.73 |
| Interest Coverage | 2.23 | 1.96 | 1.29 | 0.19 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.40 | 1.18 |
| Cash Conversion Cycle | 266.38 | 58.22 | 1,009.82 | 617.32 |